Unicycive Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$8.08(as of May 22, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Unicycive Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$8.08
Ticker SymbolUNCY
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees21
CountyUSA
Market Cap$215.7M

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI-494, a nicotinamide ester derivative and a selective ATP-sensitive mitochondrial potassium channel activator, which is in Phase I clinical trial for the treatment of acute kidney injury and pre-clinical stage for the treatment of chronic kidney disease. The company was incorporated in 2016 and is headquartered in Mountain View, California.

Unicycive Therapeutics Inc In Our Stock Scanner

As of May 26, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.